This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
MDC 株式概要
Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia.
報酬
リスク分析
+1 さらなるリスク
Medlab Clinical Limited 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | AU$6.60 |
| 52週高値 | AU$14.94 |
| 52週安値 | AU$6.45 |
| ベータ | 1.1 |
| 11ヶ月の変化 | 0% |
| 3ヶ月変化 | -4.21% |
| 1年変化 | -43.59% |
| 33年間の変化 | -79.05% |
| 5年間の変化 | -91.85% |
| IPOからの変化 | -78.00% |
最新ニュース
Recent updates
Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now
Oct 06
Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?
Oct 05What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay
Feb 21Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years
Dec 30
Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future
Nov 22株主還元
| MDC | AU Biotechs | AU 市場 | |
|---|---|---|---|
| 7D | 0% | -0.4% | 0.4% |
| 1Y | -43.6% | 18.0% | 16.4% |
業界別リターン: MDC underperformed the Australian Biotechs industry which returned 11.4% over the past year.
リターン対市場: MDC underperformed the Australian Market which returned -1.5% over the past year.
価格変動
| MDC volatility | |
|---|---|
| MDC Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 10.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in AU Market | 16.7% |
| 10% least volatile stocks in AU Market | 3.6% |
安定した株価: MDC has not had significant price volatility in the past 3 months.
時間の経過による変動: Insufficient data to determine MDC's volatility change over the past year.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2012 | n/a | Sean Hall | www.medlab.co |
Medlab Clinical Limited 基礎のまとめ
| MDC 基礎統計学 | |
|---|---|
| 時価総額 | AU$15.07m |
| 収益（TTM） | -AU$8.32m |
| 売上高(TTM) | AU$1.54m |
9.8x
P/Sレシオ-1.8x
PER（株価収益率MDC は割高か？
公正価値と評価分析を参照収益と収入
| MDC 損益計算書（TTM） | |
|---|---|
| 収益 | AU$1.54m |
| 売上原価 | AU$336.29k |
| 売上総利益 | AU$1.20m |
| その他の費用 | AU$9.52m |
| 収益 | -AU$8.32m |
直近の収益報告
Jun 30, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -3.64 |
| グロス・マージン | 78.11% |
| 純利益率 | -541.67% |
| 有利子負債／自己資本比率 | 0% |
MDC の長期的なパフォーマンスは？
過去の実績と比較を見る